News | April 01, 2023
ProBioGen delivers strong 2022 performance
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
ProBioGen was able to carry on its rapid growth trajectory by completing a significantly increased number of projects.
The San Francisco facility is part of Thermo Fisher’s global pharma services network of more than 15 locations supporting cell and gene therapies.
Department of Biotechnology is going to play an important part in the integrated holistic healthcare approach against elimination of Tuberculosis
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
hubergroup’s two newly added medical vans are dedicated to dental and eye care
All children (100%) in the presymptomatic intravenous cohort of LT-002 maintained or achieved all assessed motor milestones, including independent walking
KRIVIDA TRIVUS detects the specific virus causing a respiratory infection.
Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
Proposed combination enhances Pfizer’s position as a leading company in oncology
For the first-line treatment of patients with unresectable advanced or metastatic malignant pleural mesothelioma
Subscribe To Our Newsletter & Stay Updated
